tiprankstipranks
Trending News
More News >
Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
US Market

Allogene Therapeutics (ALLO) Technical Analysis

Compare
1,575 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Allogene Therapeutics Inc’s (ALLO) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Allogene Therapeutics Inc is a Buy.
Allogene Therapeutics Inc’s (ALLO) 20-Day exponential moving average is 1.41, while Allogene Therapeutics Inc’s (ALLO) share price is $1.38, making it a Sell.
Allogene Therapeutics Inc’s (ALLO) 50-Day exponential moving average is 1.35, while Allogene Therapeutics Inc’s (ALLO) share price is $1.38, making it a Buy.

Allogene Therapeutics (ALLO) Pivot Points

Dec 28, 2025, 10:25 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.30
1.33
1.36
1.39
1.43
1.46
1.49
Fibonacci
1.33
1.35
1.37
1.39
1.42
1.43
1.46
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Allogene Therapeutics (ALLO) Moving Averages

Dec 28, 2025, 10:25 PM
Period
Simple
Exponential
MA5
1.41Sell
1.40Sell
MA10
1.44Sell
1.42Sell
MA20
1.44Sell
1.41Sell
MA50
1.32Buy
1.35Buy
MA100
1.25Buy
1.32Buy
MA200
1.30Buy
1.41Sell
Allogene Therapeutics Inc’s (ALLO) 10-Day exponential moving average is 1.42, while Allogene Therapeutics Inc’s (ALLO) share price is $1.38, making it a Sell.
Allogene Therapeutics Inc’s (ALLO) 100-Day exponential moving average is 1.32, while Allogene Therapeutics Inc’s (ALLO) share price is $1.38, making it a Buy.
Allogene Therapeutics Inc’s (ALLO) stock price is $1.38 and Allogene Therapeutics Inc’s (ALLO) 50-day simple moving average is 1.32, creating a Buy signal.
Allogene Therapeutics Inc’s (ALLO) stock price is $1.38 and Allogene Therapeutics Inc’s (ALLO) 100-day simple moving average is 1.25, creating a Buy signal.
Allogene Therapeutics Inc’s (ALLO) stock price is $1.38 and Allogene Therapeutics Inc’s (ALLO) 200-day simple moving average is 1.30, creating a Buy signal.

Allogene Therapeutics (ALLO) Technical Indicators

Dec 28, 2025, 10:25 PM
Name
Value
Implied Action
RSI (14)
48.77
Neutral
STOCH (9,6)
24.66
Neutral
STOCHRSI (14)
24.49
Neutral
MACD (12,26)
0.02
Buy
ADX (14)
24.52
Neutral
Williams %R
-75.51
Buy
CCI (14)
-101.12
Buy
ATR (14)
0.10
-
Ultimate Oscillator
42.33
Neutral
ROC
-3.50
Sell
Allogene Therapeutics Inc’s (ALLO) Relative Strength Index (RSI) is 48.77, creating a Neutral signal.
Allogene Therapeutics Inc’s (ALLO) Trend Strength Indicator (ADX) is 24.52, creating a Neutral signal.
Allogene Therapeutics Inc’s (ALLO) Commodity Channel Index (CCI) is -101.12, creating a Buy signal.
Allogene Therapeutics Inc’s (ALLO) Price Rate of Change (ROC) is -3.50, creating a Sell signal.

FAQ

Is ALLO a Buy, Hold, or Sell?
Based on ALLO’s technical indicators, ALLO is a Hold.
    What is ALLO’s RSI (14)?
    ALLO’s RSI (14) is 48.77, which suggests ALLO is a Neutral.
      What is ALLO’s MACD?
      ALLO’s MACD is 0.02, which suggests ALLO is a Buy.
        What is ALLO’s 5-day moving average?
        ALLO’s 5-day moving average is 1.41, which suggests ALLO is a Sell.
          What is ALLO’s 20-day moving average?
          ALLO 20-day moving average is 1.44, which suggests ALLO is a Sell.
            What is ALLO’s 50-day moving average?
            ALLO’s 50-day moving average is 1.32, which suggests ALLO is a Buy.
              What is ALLO’s 200-day moving average?
              ALLO’s 200-day moving average is 1.30, which suggests ALLO is a Buy.
                What is ALLO’s Williams % R (14)?
                ALLO’s Williams % R (14) is -75.51, which suggests ALLO is a Buy.
                  What is ALLO’s CCI (14)?
                  ALLO’s CCI (14) is -101.12, which suggests ALLO is a Buy.